Astria Therapeutics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 09/08/2021   Download
SEC Document
SEC Filing

In connection with the Name Change, the Board also approved an amendment and restatement of the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Old By-laws”) to reflect the Name Change (as amended and restated, the “Amended and Restated By-laws”) effective as of September 8, 2021. There were no other changes to the Old By-laws.